A MEDICAL technology company in Reading has seen one of its medical devices move a step closer to going to market.
Occuity, which develops optical medical technology, has accelerated the bringing of one of its new diagnostic devices to healthcare in Europe.
The company has developed the world’s first handheld, non-contact optical pachymeter, the PM1.
The device measures the thickness of the cornea in an eye in a few seconds, which would make the diagnosis of glaucoma easier, faster, and safer.
Typically pachymeters rely on ultrasound to show the corneal thickn
Occuity’s new pachymeter has been awarded CE marking from the European Union, which denotes that it has been assessed to meet high safety, health, and environmental standards.
The company has now said that the device is ready for market, with commercialisation of the product now set to begin later this month.
Dr Dan Daly, CEO of Occuity, said: “Achieving CE marking is a pivotal moment for Occuity.
“It opens the door to new commercial opportunities and validates the hard work our team has put in.
“With the PM1 ready for market and a strong pipeline of products following closely behind, all built on an innovative platform that leverages Occuity’s groundbreaking optical technology, we’re poised for substantial future growth.”
More information about Occuity is available via: occuity.com
